Evidence map›Paper›PMID 42851573›Full record

ArticleFrontiers in cellular and infection microbiology2026

Co-infection models of

Giulia Radocchia, Marta De Angelis, Maria Grazia Martina, Francesca Barbieri, Rebecca De Gregorio, Sofia Venditti, Fabrizio Pantanella, Anna Teresa Palamara, Marco Radi, Serena Schippa and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Giulia Radocchia *Department of Public Health and Infectious Diseases, Sapienza University, Rome, Italy.
Marta De Angelis *Department of Public Health and Infectious Diseases, Sapienza University, Rome, Italy.
Maria Grazia MartinaDepartment of Food and Drugs, University of Parma, Parma, Italy.
Francesca BarbieriDepartment of Food and Drugs, University of Parma, Parma, Italy.
Rebecca De GregorioDepartment of Public Health and Infectious Diseases, Sapienza University, Rome, Italy.
Sofia VendittiDepartment of Public Health and Infectious Diseases, Sapienza University, Rome, Italy.
Fabrizio PantanellaDepartment of Public Health and Infectious Diseases, Sapienza University, Rome, Italy.
Anna Teresa PalamaraDepartment of Public Health and Infectious Diseases, Sapienza University, Rome, Italy.
Marco RadiDepartment of Food and Drugs, University of Parma, Parma, Italy.
Serena Schippa *Department of Public Health and Infectious Diseases, Sapienza University, Rome, Italy.
Lucia Nencioni *Department of Public Health and Infectious Diseases, Sapienza University, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Viral-bacterial co-infections represent a major contributor to global morbidity and mortality. In influenza virus infections, secondary bacterial pneumonia occurs in approximately 20-30% of cases and is associated with an increased risk of shock, mechanical ventilation, and even mortality. Bacterial superinfections are frequent causes of mortality in influenza severe infections and have been a major cause of morbidity and mortality also in COVID-19 patients.

Indexed as

Anti-Bacterial AgentsAntiviral AgentsCoinfectionStaphylococcal InfectionsStaphylococcus aureusThiazolesAnimalsDogsDrug SynergismHumansInfluenza A virusSARS-CoV-2Anti-Bacterial AgentsAntiviral AgentsThiazolesantimicrobial activityantiviralsbithiazole derivativeco-infectionscoronavirusinfluenza virusStaphylococcus aureus

Identifiers

PMID42851573
PMCPMC13645707

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.